These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9692220)

  • 21. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells.
    Sato W; Yusa K; Naito M; Tsuruo T
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1252-7. PubMed ID: 1980066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
    Reinecke P; Knopf C; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer; 2000 Apr; 88(7):1614-22. PubMed ID: 10738220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
    Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
    J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
    Matsumoto T; Tani E; Yamaura I; Miyaji K; Kaba K
    Neurosurgery; 1995 Mar; 36(3):565-71; discussion 572. PubMed ID: 7538636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.
    Ushigome F; Takanaga H; Matsuo H; Yanai S; Tsukimori K; Nakano H; Uchiumi T; Nakamura T; Kuwano M; Ohtani H; Sawada Y
    Eur J Pharmacol; 2000 Nov; 408(1):1-10. PubMed ID: 11070177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
    Draper MP; Martell RL; Levy SB
    Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.
    Liu B; Staren E; Iwamura T; Appert H; Howard J
    World J Gastroenterol; 2001 Feb; 7(1):143-8. PubMed ID: 11819752
    [No Abstract]   [Full Text] [Related]  

  • 31. Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel.
    Jelínek M; Balušíková K; Daniel P; Němcová-Fürstová V; Kirubakaran P; Jaček M; Wei L; Wang X; Vondrášek J; Ojima I; Kovář J
    Toxicol Appl Pharmacol; 2018 May; 347():79-91. PubMed ID: 29625142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
    Fong WF; Shen XL; Globisch C; Wiese M; Chen GY; Zhu GY; Yu ZL; Tse AK; Hu YJ
    Bioorg Med Chem; 2008 Apr; 16(7):3694-703. PubMed ID: 18313307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of P-glycoprotein and multidrug-resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine K.
    Okumura H; Chen ZS; Sakou M; Sumizawa T; Furukawa T; Komatsu M; Ikeda R; Suzuki H; Hirota K; Aikou T; Akiyama SI
    Mol Pharmacol; 2000 Dec; 58(6):1563-9. PubMed ID: 11093797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
    Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of P-glycoprotein mediated multidrug resistance by stemofoline derivatives.
    Umsumarng S; Pintha K; Pitchakarn P; Sastraruji K; Sastraruji T; Ung AT; Jatisatienr A; Pyne SG; Limtrakul P
    Chem Pharm Bull (Tokyo); 2013; 61(4):399-404. PubMed ID: 23358236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.
    Cornwell MM; Tsuruo T; Gottesman MM; Pastan I
    FASEB J; 1987 Jul; 1(1):51-4. PubMed ID: 2886389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inostamycin, an inhibitor of P-glycoprotein function, interacts specifically with phosphatidylethanolamine.
    Kawada M; Umezawa K
    Jpn J Cancer Res; 1995 Sep; 86(9):873-8. PubMed ID: 7591966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An efficient conversion of taxinine to taxinine NN-1, an anticancer agent and a modulator of multidrug-resistant tumor cells.
    Zhang S; Wang J; Hirose K; Ando M
    J Nat Prod; 2002 Dec; 65(12):1786-92. PubMed ID: 12502315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.